Загрузка...
Stem and progenitor cell alterations in myelodysplastic syndromes
Recent studies have demonstrated that myelodysplastic syndromes (MDSs) arise from a small population of disease-initiating hematopoietic stem cells (HSCs) that persist and expand through conventional therapies and are major contributors to disease progression and relapse. MDS stem and progenitor cel...
Сохранить в:
| Опубликовано в: : | Blood |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Hematology
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5364336/ https://ncbi.nlm.nih.gov/pubmed/28159737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-10-696062 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|